Author

Jon Ramsey

University of Vermont

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cell type annotation· 1 Assay:organoid / primary culture· 1 Research Focus:perturbation response prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

Madison GuyetteiD· 2 shared NIMRAT CHATTERJEEiD· 2 shared Sombodhi BhattacharyaiD· 2 shared Vihit GuptaiD· 2 shared Adam L. Viens· 1 shared Andrew CromptoniD· 1 shared Andrew J. FritziD· 1 shared Deli HongiD· 1 shared

Activity by Year

2018-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Madison GuyetteORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting REV1 Exposes Context-Dependent Therapeutic Responses in Colorectal Cancer

Vihit Gupta, Madison Guyette, Sombodhi Bhattacharya, Joshua Victor, Naveen Kothandaraman, Katherine A. Boyle, Jon P. Girard, Jiyong Hong, Jon Ramsey, Pei Zhou, NIMRAT CHATTERJEE

This study shows that targeting REV1 in colorectal cancer enhances chemotherapy sensitivity in a context-dependent manner and inhibits organoid growth.

bioRxiv · Nov 6, 2026 · PreprintCancer Biology

Targeting REV7 exposes a mitotic vulnerability in colorectal cancer cells

Madison Guyette, Sombodhi Bhattacharya, Naveen Kothandaraman, Vihit Gupta, Andrew Crompton, Katherine Boyle, Noah J. Harrahill, Jon Ramsey, Dmitry M. Korzhnev, Matthew Kyle Hadden, Nimrat Chatterjee

This study shows that targeting REV7 with C10 sensitizes colorectal cancer cells to microtubule disruption, revealing a mitotic vulnerability.

bioRxiv · Sep 30, 2026 · PreprintCancer Biology

RUNX1 suppresses breast cancer stemness and tumor growth

Deli Hong, Andrew J. Fritz, Kristiaan H. Finstad, Mark P. Fitzgerald, Adam L. Viens, Jon Ramsey, Janet L. Stein, Jane B. Lian, Gary S. Stein

This study shows that Runx1 suppresses breast cancer stemness and tumor growth by inhibiting Zeb1 and epithelial-mesenchymal transition.

bioRxiv · May 4, 2018 · PreprintCancer Biology